InvestorsHub Logo
Followers 2
Posts 253
Boards Moderated 0
Alias Born 06/04/2007

Re: None

Friday, 10/09/2009 7:09:36 AM

Friday, October 09, 2009 7:09:36 AM

Post# of 1874
IRG Podcast - Dr Brad Thompson Interview

More Ph III SPAs on the way??

http://irgnews.com/podcast/episode22

Highlights for me...

The US phase II H&N trial is almost finished..."With the REOLYSIN/chemo combination treatment we are seeing a 40% response rate, which is 5-10 times the response rate one expects to see in this patient group. Progression free survival is at least 3 times what one expects to see in this patient group." <<It fits that positive maybe very positive data should be announced soon>>

Phase III SPA is double blinded, Part A is 80 patients and allows unblinding the data. And data to be available in "one year, plus or minus a quarter"

Already writing several other SPA protocols. One will be submitted in 2009 and one in 2010. <<YES!>>

Worth a listen

onco_investor
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News